Altered gut microbiota in RA: implications for treatment

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• Rheumatoid arthritis (RA) is an autoimmune disease characterized by progressive joint disorder.
• The development of RA involves complex genetic and environmental factors.
• Emerging evidence links gut microbiota dysbiosis to RA pathogenesis.

Purpose of the Study:

• To review the role of gut microbiota in RA progression.
• To explore how specific gut bacterial strains modulate immune responses in RA.
• To discuss the potential of probiotics and prebiotics as therapeutic strategies for RA.

Main Methods:

• Literature review of studies investigating the gut microbiome in RA.
• Analysis of research on bacterial strain-specific immune modulation in RA models.
• Synthesis of data on the efficacy of probiotics and prebiotics in RA treatment.

Main Results:

• Gut microbial dysbiosis is associated with RA development.
• Specific gut commensal bacteria can exhibit either pathogenic or protective roles in RA.
• Probiotics and prebiotics show potential for immune regulation in RA.

Conclusions:

• The gut microbiota plays a significant role in RA progression.
• Targeting gut bacteria with probiotics/prebiotics is a promising therapeutic avenue for RA.
• Further research is needed to fully elucidate the gut microbiota's impact on RA and optimize probiotic/prebiotic interventions.